Exparel (bupivacaine liposomal) is a brand-name drug prescribed for pain relief after surgery in adults and some children. Exparel comes as an injection that’s given as a single dose by a healthcare ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Plastic surgery has become increasingly popular, with ...
BRISBANE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Wisdom teeth extractions are a very common procedure in the ...
Aetna launched a pilot program in Florida and New Jersey where select ASCs will be reimbursed for using Exparel to incentivize non-opioid therapies for postsurgical pain management. Here are the key ...
-- Select findings demonstrate that the use of EXPAREL® (bupivacaine liposome injectable suspension) in outpatient Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) is associated with ...
TAMPA, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
An injectable anesthetic may be able to dull pain after major implant surgery. A recent study found that the bupivacaine liposome injectable suspension Exparel significantly reduced pain for patients ...
Findings presented at ISPOR 2026 showed lower opioid consumption, reduced healthcare costs, and fewer opioid-related adverse events associated with EXPAREL use BRISBANE, Calif., May 27, 2026 (GLOBE ...
PARSIPPANY, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced the publication of its multinational Phase 3 study supporting the efficacy and safety of ...
BRISBANE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...